Operationalize FDA guidance for industry decentralized clinical trials with ProRelix Research. 21 CFR Part 11 eConsent, eCOA, and DtP logistics. Request a quote. Operationalizing FDA Guidance for Industry on Decentralized Clinical Trials: Mitigating Sponsor Risk in Hybrid Studies Executive Summary …
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.